Avantax Planning Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $216K | Sell |
|
|||||
|
2025
Q2 | $253K | Buy |
|
|||||
|
2025
Q1 | $303K | Sell |
|
|||||
|
2024
Q4 | $346K | Buy |
|
|||||
|
2024
Q3 | $496K | Sell |
|
|||||
|
2024
Q2 | $497K | Sell |
|
|||||
|
2024
Q1 | $456K | Buy |
|
|||||
|
2023
Q4 | $280K | Hold |
|
|||||
|
2023
Q3 | $263K | Buy |
|
|||||
|
2023
Q2 | $228K | Hold |
|
|||||
|
2023
Q1 | $260K | Hold |
|
|||||
|
2022
Q4 | $229K | Hold |
|
|||||
|
2022
Q3 | $218K | Sell |
|
|||||
|
2022
Q2 | $217K | Hold |
|
|||||
|
2022
Q1 | $256K | Hold |
|
|||||
|
2021
Q4 | $232K | Hold |
|
|||||
|
2021
Q3 | $222K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $6K | Buy |
|